Patents Assigned to Greenyn Biotechnology Co., Ltd.
  • Patent number: 11759488
    Abstract: The invention provides a usage of a Antrodia cinnamomea powder for preparation of a composition for dispelling the effects of alcohol, which means that by administering an effective amount of the Antrodia cinnamomea powder disclosed in the invention to an subject, is capable of accelerating metabolism of alcohol and/or acetaldehyde in the subject's body, reducing a content of alcohol and/or acetaldehyde in blood, and shortening the time of the subject generating intoxicated reaction in order to achieve an efficacy of dispelling the effects of alcohol.
    Type: Grant
    Filed: March 16, 2021
    Date of Patent: September 19, 2023
    Assignee: GREENYN BIOTECHNOLOGY CO., LTD
    Inventors: Pang-Kuei Hsu, Chia-Feng Wu
  • Patent number: 11602520
    Abstract: The invention discloses a c-Met regulatory composition and its method for treating liver disease, a main component of the c-Met regulatory composition comprises Antrodin A and/or DMB (4,7-Dimethoxy-5-methyl-1,3-benzodioxole) capable of effectively regulating gene expression related to cell regeneration and cytothesis in hepatic cells, such as c-Met, Notch, etc., to achieve efficacies of repairing damaged hepatic cells and promoting hepatocyte regeneration.
    Type: Grant
    Filed: October 14, 2021
    Date of Patent: March 14, 2023
    Assignee: GREENYN BIOTECHNOLOGY CO., LTD
    Inventors: Pang-Kuei Hsu, Chun-Yi Ho, Chia-Feng Wu
  • Patent number: 11149239
    Abstract: This invention disclosed a method for preparing low-sugar vegetable and fruit enzyme product comprising obtaining a fruit or/and vegetable as a material; fermenting the material for at least three times sequentially, and producing an enzyme product, wherein the first fermentation is yeast fermentation, the second fermentation is acetic acid bacteria fermentation and the third fermentation is lactic acid bacteria fermentation; and the sugar content of the enzyme product is less than 5 wt %, especially, in a predetermined fermentation condition, the sugar content of the enzyme product is less than 2.5 wt %.
    Type: Grant
    Filed: May 1, 2019
    Date of Patent: October 19, 2021
    Assignee: Greenyn Biotechnology Co., Ltd
    Inventors: Pang-Kuei Hsu, Yu-Cheng Lin, Chia-Feng Wu
  • Patent number: 10356988
    Abstract: This present invention disclosed a method for culturing Ophiocordyceps sinensis by inoculating a fungus inoculum onto a medium, culturing with a culturing condition in the dark room, and then culturing under the light for at least four weeks. According to the method for culturing O. sinensis disclosed in this present invention, the cultured O. sinensis has better growth rate and its composition and content of active ingredients are similar with wild O. sinensis.
    Type: Grant
    Filed: April 19, 2016
    Date of Patent: July 23, 2019
    Assignees: Tunghai University, Greenyn Biotechnology Co., Ltd
    Inventors: Fan-Chiang Yang, Yi-Chuan Shih
  • Patent number: 10285972
    Abstract: The present invention discloses a method for producing trans-2-nonadecyl-4-hydroxymethyl-1,3-dioxolane comprising mixing alkanes and pyridinium chlorochromat for an oxidation reaction; obtaining a product by the oxidation reaction for processing an aldolization reaction and then purifying for obtaining a trans-2-nonadecyl-4-hydroxymethyl-1,3-dioxolane compound. According to the method of the present invention, it is able to promote the productivity and reduce the cost.
    Type: Grant
    Filed: August 4, 2016
    Date of Patent: May 14, 2019
    Assignees: GREENYN BIOTECHNOLOGY CO., LTD
    Inventors: Min-Hsiung Pan, Chi-I Chang, Chia-Feng Wu, Pang-Kuei Hsu
  • Patent number: 9458421
    Abstract: The invention discloses a culture method for Antrodia cinnamomea to elevate the amounts and types of the bioactive components in Antrodia cinnamomea through controlling the wavelength and intensity of the light. Furthermore, the modification of the environmental factors such as water content, composition and relative amount of the culture medium, and the culture temperature are capable of increasing the amounts and types of the bioactive components in Antrodia cinnamomea.
    Type: Grant
    Filed: January 6, 2014
    Date of Patent: October 4, 2016
    Assignees: TUNGHAI UNIVERSITY, GREENYN BIOTECHNOLOGY CO., LTD.
    Inventors: Fan-Chiang Yang, Chia-Li Wu, Ya-Chen Chi
  • Publication number: 20150051272
    Abstract: The invention discloses the uses of hydroxyl polymethoxylflavones and derivative thereof that are relative to inhibit adipogenesis and lower lipid accumulation, wherein the hydroxyl polymethoxylflavones is obtained from the peels of Citrus genus plants. Therefore, the hydroxyl polymethoxylflavones that of a therapeutically effective amount not only can be a medical compound for treatment obesity or fatty liver, but also can be a food element.
    Type: Application
    Filed: January 28, 2014
    Publication date: February 19, 2015
    Applicants: Greenyn Biotechnology Co., Ltd
    Inventors: Min-Hsiung PAN, Chia-Li WU
  • Publication number: 20150052639
    Abstract: The invention discloses a culture method for Antrodia cinnamomea to elevate the amounts and types of the bioactive components in Antrodia cinnamomea through controlling the wavelength and intensity of the light. Furthermore, the modification of the environmental factors such as water content, composition and relative amount of the culture medium, and the culture temperature are capable of increasing the amounts and types of the bioactive components in Antrodia cinnamomea.
    Type: Application
    Filed: January 6, 2014
    Publication date: February 19, 2015
    Applicants: Greenyn Biotechnology Co., Ltd., Tunghai University
    Inventors: Fan-Chiang YANG, Chia-Li WU, Ya-Chen CHI
  • Patent number: 8946288
    Abstract: The invention discloses the uses of hydroxyl polymethoxylflavones and derivative thereof that are relative to inhibit adipogenesis and lower lipid accumulation, wherein the hydroxyl polymethoxylflavones is obtained from the peels of Citrus genus plants. Therefore, the hydroxyl polymethoxylflavones that of a therapeutically effective amount not only can be a medical compound for treatment obesity or fatty liver, but also can be a food element.
    Type: Grant
    Filed: January 28, 2014
    Date of Patent: February 3, 2015
    Assignees: Greenyn Biotechnology Co., Ltd.
    Inventors: Min-Hsiung Pan, Chia-Li Wu